HUMANIGEN, INC.
HGEN
HGEN was delisted on the 25th of July, 2023.
27 hedge funds and large institutions have $141M invested in HUMANIGEN, INC. in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Valiant Capital Management
San Francisco,
California
|
+$72.6M |
| 2 |
TI
Think Investments
San Francisco,
California
|
+$13.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$13.5M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$8.47M |
| 5 |
BlackRock
New York
|
+$7.19M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| – | +$10 | +1 | New |
|
|
VNA
27
Valley National Advisers
Bethlehem,
Pennsylvania
| – | +$41 | +4 | New |
|
HGEN Hedge Fund Activity: Q3 2020 in Review
27 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q3 2020, worth a combined $141M.
Buyers outnumbered sellers: 27 funds opened new HGEN positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Valiant Capital Management, opening a new position worth an estimated $72.6M.
- 27 institutional investors held HUMANIGEN, INC. (HGEN) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $141M of HUMANIGEN, INC. stock for Q3 2020.
- 27 funds opened new HUMANIGEN, INC. positions in Q3 2020 and 0 closed out, a net change of +27 holders.
- The largest HUMANIGEN, INC. buyer in Q3 2020 was Valiant Capital Management, an estimated $72.6M added.
Based on aggregated 13F filings for Q3 2020.